These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25549947)

  • 1. Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations.
    Teitelbaum SL; Belpoggi F; Reinlib L
    Reprod Toxicol; 2015 Jul; 54():141-7. PubMed ID: 25549947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating chemical effects on mammary gland development: A critical need in disease prevention.
    Osborne G; Rudel R; Schwarzman M
    Reprod Toxicol; 2015 Jul; 54():148-55. PubMed ID: 25091782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental exposures, breast development and cancer risk: Through the looking glass of breast cancer prevention.
    Forman MR; Winn DM; Collman GW; Rizzo J; Birnbaum LS
    Reprod Toxicol; 2015 Jul; 54():6-10. PubMed ID: 25499721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A special issue dedicated to a complex tissue.
    Fenton SE
    Reprod Toxicol; 2015 Jul; 54():1-5. PubMed ID: 25986312
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer.
    Paulose T; Speroni L; Sonnenschein C; Soto AM
    Reprod Toxicol; 2015 Jul; 54():58-65. PubMed ID: 25277313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine disruptors and the breast: early life effects and later life disease.
    Macon MB; Fenton SE
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):43-61. PubMed ID: 23417729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. California Breast Cancer Prevention Initiatives: Setting a research agenda for prevention.
    Sutton P; Kavanaugh-Lynch MH; Plumb M; Yen IH; Sarantis H; Thomsen CL; Campleman S; Galpern E; Dickenson C; Woodruff TJ
    Reprod Toxicol; 2015 Jul; 54():11-8. PubMed ID: 25277312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer.
    Treviño LS; Wang Q; Walker CL
    Reprod Toxicol; 2015 Jul; 54():136-40. PubMed ID: 25554384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.
    Fenton SE
    Endocrinology; 2006 Jun; 147(6 Suppl):S18-24. PubMed ID: 16690811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
    Hilakivi-Clarke L; de Assis S; Warri A
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):25-42. PubMed ID: 23392570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired mitochondrial metabolism and mammary carcinogenesis.
    Yadava N; Schneider SS; Jerry DJ; Kim C
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):75-87. PubMed ID: 23269521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Environmental endocrine disruptors and breast cancer: new risk factors?].
    Fénichel P; Brucker-Davis F
    Gynecol Obstet Fertil; 2008 Oct; 36(10):969-77. PubMed ID: 18805035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixtures of environmentally relevant endocrine disrupting chemicals affect mammary gland development in female and male rats.
    Mandrup KR; Johansson HK; Boberg J; Pedersen AS; Mortensen MS; Jørgensen JS; Vinggaard AM; Hass U
    Reprod Toxicol; 2015 Jul; 54():47-57. PubMed ID: 25305543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US EPA's regulatory pesticide evaluations need clearer guidelines for considering mammary gland tumors and other mammary gland effects.
    Cardona B; Rudel RA
    Mol Cell Endocrinol; 2020 Dec; 518():110927. PubMed ID: 32645345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research.
    Terry MB; Michels KB; Brody JG; Byrne C; Chen S; Jerry DJ; Malecki KMC; Martin MB; Miller RL; Neuhausen SL; Silk K; Trentham-Dietz A;
    Breast Cancer Res; 2019 Aug; 21(1):96. PubMed ID: 31429809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IGF system in mammary development and breast cancer. Preface.
    Yee D; Wood TL
    J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):351-2. PubMed ID: 19030973
    [No Abstract]   [Full Text] [Related]  

  • 17. Preface: prolactin and growth hormone in mammary gland development and breast cancer.
    J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):1. PubMed ID: 18236141
    [No Abstract]   [Full Text] [Related]  

  • 18. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.
    Rudel RA; Fenton SE; Ackerman JM; Euling SY; Makris SL
    Environ Health Perspect; 2011 Aug; 119(8):1053-61. PubMed ID: 21697028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of Environmental Exposures as a Critical Element in Breast Cancer Risk.
    Fenton SE; Birnbaum LS
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3245-50. PubMed ID: 26214118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms.
    Rodgers KM; Udesky JO; Rudel RA; Brody JG
    Environ Res; 2018 Jan; 160():152-182. PubMed ID: 28987728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.